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nCPAPAbstract The prevalence of GER disease (GERD) is as high as 20% in the Western world with up
to 10% of people reporting symptoms of nocturnal reﬂux exclusively. Obstructive sleep apnea
(OSA) has estimation of affection in 4% of men and 2% of women in USA and the rates continue
to increase. The aim of this work is to determine the frequency of OSA in patients with GERD
studying the association between GERD and OSA, and to evaluate the effect of nCPAP on GERD
symptoms.
Subjects and methods: One hundred and thirty-six subjects suspected to have GERD were sub-
jected to the following: (1) thorough medical history stressing on OSA symptoms, (2) clinical exam-
ination, (3) chest X-ray, (4) routine investigations (complete blood count, liver and kidney
functions, fasting blood sugar), (5) upper GIT endoscopy, (6) Epworth questionnaire, and (7)
polysomnography for patients who were suspected to have sleep-disordered breathing upon
Epworth questionnaire (109 patients). The patients were classiﬁed according to endoscopic ﬁndings
into 2 groups: Group I: erosive reﬂux disease (ERD) group which included 65 patients; 42 males
and 23 females with a mean age of 55.3 ± 7.2 and Group II: non-erosive reﬂux disease (NERD)
group which included 71 patients; 49 males and 22 females with a mean age of 53.8 ± 6.8. Nasal
CPAP therapy was prescribed for all OSA patients (41 patients diagnosed by polysomnography)
according to the clinical protocol then they were further recruited for post nCPAP therapy assess-
ment. All the following parameters were measured at time of recruitment and 1 week later after ini-
tiation of nCPAP: BMI, pulmonary function tests: FEV1% and FVC%, sleep characteristics: AHI
(event/hour slept), arousal index (event/hour slept), minimum SpO2 (%), SpO2 (%), total sleep time
(min), sleep efﬁciency index (%) and GER symptoms including nocturnal GER (nGER).
Results: There was a statistically signiﬁcant high frequency of OSA among NERD patients than
that among ERD ones. Also there was a statistically highly signiﬁcant increase in apnea/hypopnea
798 A. Shaker, M. Magdyindex (AHI) (event/hour) and arousal index (AI) (event/hour) in NERD group than that in ERD
one. A statistically signiﬁcant increase in total sleep time (min) and Epworth sleepiness scale score
was found in NERD group when compared to ERD one. There were statistically highly signiﬁcant
decreased percentages of OSA patients who had any nocturnal symptoms and frequent nocturnal
symptoms after use of nCPAP and also a statistically highly signiﬁcant decrease in GERD score
in OSA patients after nCPAP therapy.
Conclusion: (1) A high risk for OSA development is more frequent in GERD patients especially
NERD ones and who experience nighttime symptoms, (2) there is a mutual relationship between
OSA and GERD reinforcing each other, and (3) CPAP therapy has a good role in the treatment
of both OSA and GERD symptoms.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Obstructive sleep apnea (OSA) is a condition characterized by
repetitive sleep related obstruction of the upper airway which
leads to oxygen desaturation and arousals from sleep [1]. Gas-
troesophageal reﬂux (GER) is a chronic condition in which
gastric contents enter and remain in the lower esophagus,
and without treatment, can lead to esophagitis, Barrett’s
esophagus, bleeding and cancer [2]. A relationship between
GER and OSA has been suggested with patients being predis-
posed to both conditions, with the same etiologic risk factors
such as obesity and alcohol use [3]. ‘‘The prevalence of GER
disease (GERD) is as high as 20% in the Western world with
up to 10% of people reporting symptoms of nocturnal reﬂux
exclusively” [4]. OSA has estimation of affection in 4% of
men and 2% of women in USA and the rates continue to
increase [5]. The aim of this work is to determine the frequency
of OSA in patients with GERD studying the association
between GERD and OSA, and to evaluate the effect of nCPAP
on GERD symptoms.
Subjects and methods
This study was conducted from December 2013 to November
2015 in Chest and Tropical Departments, Zagazig University
Hospitals. Full written consent was taken from all patients
enrolled in this study before taking and performing any
procedure.
Potential subjects reporting symptoms of GERD were
recruited from gastroenterology outpatient clinic. They were
185 subjects with a mean age of 55.2 ± 7.2 years.
These symptoms included heartburn and/or acid regurgita-
tion P3 times a week [6].
Exclusion criteria [6,7]
1. Using anti-reﬂux medication.
2. Use of drugs as psychotropics, narcotics or benzodiazepines
which might affect sleep architecture or subjective sleep
quality.
3. Known psychological disorders as depression and anxiety.
4. Other medical comorbidities that might interfere with sleep
quality such as bronchial asthma, chronic obstructive pul-
monary disease (COPD), renal failure or other systemic dis-
eases requiring medical therapy.5. History of gastrointestinal surgery, peptic ulcer disease or
gastroduodenal neoplasm.
Diagnosis of GERD was achieved on clinical basis. Patients
were required to have a history of GERD symptoms (e.g.
heartburn and regurgitation) [8]. These patients were subjected
to the following reﬂux questionnaire [9]. The subjects were
asked to respond to questions regarding the weekly frequency
of typical reﬂux symptoms such as heartburn and acid regurgi-
tation and to rate them on a scale of 1–5; (0): none, (1): less
than once a month, (2): approximately once a week, (4): more
than twice a week and (5): every day.
One hundred thirty-six subjects from 185 were suspected to
have GERD. Those patients (136) were subjected to the
following:
1. Thorough medical history stressing on OSA symptoms:
- day time symptoms (excessive day time sleepiness, day
time fatigue, tiredness, morning headache, cognitive
defects, morning confusion, impaired concentration,
personality and mood changes and loss of libido), and
- nocturnal symptoms (snoring, dry mouth, witnessed
apneas, gasping and choking sensations, nocturia,
insomnia, nocturnal enuresis, sweating) [10].
2. Clinical examination (general and local).
3. Chest X-ray (postero-anterior and lateral views).
4. Routine investigations:
- Complete blood count (CBC).
- Liver and kidney functions.
- Fasting blood sugar.
5. Upper GIT endoscopy.
6. Epworth questionnaire.
7. Polysomnography for patients who were suspected to have
sleep-disordered breathing upon Epworth questionnaire
(109 patients).
Upper GIT endoscopy
Upper endoscopy should be performed in all patients
with classic symptoms of GERD who also report alarm symp-
toms (dysphagia, odynophagia, weight loss, anorexia,
evidence of gastrointestinal bleeding or iron deﬁciency anemia)
[11].
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eral decubitus position and sedation was achieved with a com-
bination of midazolam and meperidine. The endoscope
(Olympus GIF 140) was inserted via the mouth and into the
esophagus. Careful examination of the distal esophagus was
performed to determine the presence of mucosal injury [6].
Endoscopic ﬁndings for GERD were described according
to the Los Angeles (LA) classiﬁcation of esophagitis [12].
The patients were classiﬁed according to endoscopic ﬁnd-
ings into 2 groups:
Group I: erosive reﬂux disease (ERD) group included 65
patients; 42 males and 23 females with a mean age of 55.3
± 7.2.
ERD: was deﬁned as endoscopy ﬁndings indicating muco-
sal breaks at the gastroesophageal junction, classiﬁed as from
A to D according to LA classiﬁcation [12].
Group II non-erosive reﬂux disease (NERD) group
included 71 patients; 49 males and 22 females with a mean
age of 53.8 ± 6.8.
NERD: patients are those experienced typical GERD
symptoms such as heartburn or acid regurgitation for more
than once a week but didn’t experience erosive esophagitis.
If a patient had symptoms but had minimal changes at gastroe-
sophageal junction, then the patient was excluded from ERD
group and included in NERD group [12].
Epworth sleepiness scale score [13]
It was done for all patients with GERD (no = 136) to deﬁne
the severity of day time hypersomnolence. It is a self report
questionnaire which measures an individual’s likelihood of
falling asleep in routine life situations. Patients who were sus-
pected to have OSA upon Epworth questionnaire would be
subjected to polysomnography.
Sleep study (polysomnography)
Polysomnography was started at 9 P.M. and ended at 6.30 A.
M. All patients suspected to have OSA (109 patients) under-
went an overnight sleep study using a computerized
polysomnogram system (Somno Screen plus RC Compi Porta-
ble Polysomnography, Somnomedics, Co., Germany) at the
sleep laboratory, Chest Department, Zagazig University. Six-
teen channels were used to document the following parame-
ters: Sleep stages (4-channel, EEG), electrooculogram, Chin
electromyogram, ECG, airﬂow at nose and mouth (thermis-
tors), chest and abdominal respiratory movement (respiratory
impedance), oxygen saturation (pulse oximetry), snoringTable 1 Demographic data of GERD patients according to GERD
Parameter All studied patients (n= 136)




BMI (kg/m2) (mean ± SD) 34.18 ± 5.74
Cigarette smoking, No. (%) 18 (13.2%)
Nocturnal GER, No. (%) 31(22.8%)(microphone), and body position. Recordings were manually
scored according to standard criteria [14]. Apnea was deﬁned
as cessation of airﬂow for >10 s, and hypopnea was deﬁned
as obvious decrease in airﬂow from baseline (650%) associ-
ated with a fall in oxygen saturation P4% from baseline [15].
After polysomnography study of 109 patients, 41 patients
had OSA as AHI >5 and 68 patients didn’t have OSA as they
were symptomatic but AHI <5.
All GERD patients with OSA snored and reported excessive
day time sleepiness or two or more other features such as
impaired concentration, unrefreshing sleep, witnessed apneas,
restless sleep and irritability/personality changes [16].
Nasal CPAP therapy
It was prescribed for all OSA patients (41) according to the
clinical protocol, and all of them agreed to try nCPAP therapy.
The patients received 1 week CPAP treatment at the optimal
therapeutic level as determined in the initial polysomnography.
They were further recruited for post nCPAP therapy assess-
ment [17].
All the following parameters were measured at time of
recruitment and 1 week later after initiation of nCPAP [17]:
1. BMI was calculated from body weight and height measured
by a scale (Detecto Scale, Webb City, MO).
2. Pulmonary function tests: FEV1% and FVC%.
3. Sleep characteristics: AHI (event/hour slept), arousal index
(event/hour slept), minimum SpO2 (%), SpO2 (%), total
sleep time (min), and sleep efﬁciency index (%).
4. GER symptoms including nocturnal GER (nGER).
Results
Table 1 shows statistically non-signiﬁcant differences between
ERD group and NERD one as regards age, sex, BMI, cigarette
smoking and nGER (P> 0.05). Table 2 shows statistically sig-
niﬁcant high frequency of OSA among NERD patients than
that among ERD ones (P= 0.0363). Table 3 shows that there
was no statistically signiﬁcant difference between GERD
patients with or without OSA regarding age, sex, BMI and
cigarette smoking (P> 0.05). Table 4 shows the polysomno-
graphic data of GERD patients who have OSA. Table 5 shows
a statistically highly signiﬁcant increase in apnea/hypopnea
index (AHI) (event/hour) and arousal index (AI) (event/hour)
in NERD group than that in ERD one (P< 0.0001) and
(P= 0.0002) respectively. A statistically signiﬁcant increaseendoscopic ﬁndings.
ERD group (n= 65) NERD group (n= 71) P-value
55.3 ± 7.2 53.8 ± 6.8 0.2137
42 (64.6%) 49 (69%) 0.586
23 (35.4%) 22 (31%)
34.25 ± 5.56 34.11 ± 6.03 0.8886
11 (16.9%) 7 (9.9%) 0.229
12 (18.5%) 19 (26.8%) 0.2494
Table 2 Frequency of OSA among GERD patients, and in
ERD and NERD subgroups.
OSA
(n= 41)






No. (41) 14 27 0.0363
% (30.15) 21.54 38.03
Table 4 Polysomnographic data of GERD patients who have
OSA (No. = 41).
Parameter Mean ± SD
AHI (event/hour) 48.32 ± 13.08
Arousal index (event/hour) 43.7 ± 11.21
Total sleep time (min) 390 ± 65
Sleep eﬃciency index (%) 68 ± 12.5
Minimum SpO2 (%) 66.72 ± 17.1
SpO2 (%) 86.31 ± 6.73
Epworth sleepiness scale score 16 ± 7
Table 5 Polysomnographic data of GERD patients with OSA
in relation to their upper GIT endoscopic ﬁndings.





AHI (event/hour) 31.01 ± 9.62 48.92 ± 13.3 <0.0001
Arousal index
(event/hour)
29.32 ± 8.51 44.2 ± 11.81 0.0002
Total sleep time
(min)
345 ± 52 392 ± 65 0.0245
Sleep eﬃciency
index (%)
72 ± 15.3 66 ± 12.1 0.1771
Minimum SpO2 (%) 71.41 ± 15.01 65.5 ± 16.3 0.2654
SpO2 (%) 88.53 ± 19.01 82.3 ± 18.7 0.3206
Epworth sleepiness
scale score
14 ± 3 17 ± 4.3 0.0253
800 A. Shaker, M. Magdyin total sleep time (min) and Epworth sleepiness scale score
was found in NERD group when was compared to ERD
one (P= 0.0245) and (P= 0.0253) respectively. Table 6
shows statistically highly signiﬁcant decreased percentages of
OSA patients who had any nocturnal symptoms and frequent
nocturnal symptoms after use of nCPAP (P= 0.0004) and
(P= 0.0077) respectively, also, a statistically highly signiﬁcant
decrease in GERD score in OSA patients after nCPAP therapy
(P< 0.0001).
Discussion
Nocturnal heartburn and its affection on sleep became an
important issue. ‘‘Reﬂux symptoms are common in patients
referred to sleep laboratories for unexplained daytime sleepi-
ness”. It is common that patients with reﬂux symptoms have
arousal from sleep and their sleep-related quality of life is
worse [18]. ‘‘GERD can be associated with OSA in general
population”. Recent studies observed that there is a close cor-
relation between symptomatic GERD and OSA. ‘‘But the cau-
sative relationship still is not clear”. The frequency of GERD
is near to 60% in OSA patients compared to only 20% in gen-
eral population [3]. ‘‘Patients with OSA are at a signiﬁcant risk
for nocturnal GER” [19]. Although there is information about
the epidemiologic link between those conditions, the exact nat-
ure of the link between GERD and OSA is complicated and
incompletely known. ‘‘Speciﬁcally, it is unclear whether the
co-occurrence of these conditions represents a causal relation-
ship or is simply a reﬂection of shared risk factors” [8]. As the
co-occurrence of GERD and sleep disorders is still controver-
sial, the aim of this study is to determine the frequency of OSA
in patients with GERD studying the association between
GERD and OSA, and to evaluate the effect of nCPAP on
GERD symptoms. In this study, there were statistically non-
signiﬁcant differences between NERD and ERD groups
regarding age, sex, BMI, cigarette smoking and nGER symp-
toms (Table 1). Multivariate analyses showed a higher riskTable 3 Demographic characteristics of GERD patients underwent
those did not have OSA.
Parameter GERD patients who have OSA (n= 41




BMI (kg/m2) (mean ± SD) 34.12 ± 5.11
Cigarette smoking, No. (%) 8 (19.5%)of any of frequent nGER symptoms with increasing age. Our
result is in consistent with some previous reports of an
increased risk of GER symptoms with increasing age [20,21],
although others have observed no effect of age [22]. Gender
is not an independent factor that can affect the risk of any
or frequent nGER symptoms in the general population [23].
Our result is in consistence with this ﬁnding and also with pre-
vious studies of either nGER or GER symptoms [19,24]. But
our result is in disagreement with those of Valipour et al.
[25] who found a 60% increased risk of overall GER
symptoms for females but this increase was statistically non-
signiﬁcant. The mechanism by which increased BMI may attri-
bute to GER has yet to be known clearly but ‘‘could relate to
the effect of raised intragastric pressure in obese individuals
and resultant increase in gastroesophageal pressure gradient”
[26]. Also the obese individuals are more prone to have hiatus
hernia which itself is an independent risk factor of GER [27].polysomnography (No. = 109) who have OSA in comparison to
) GERD patients who did not have OSA (n= 68) P-value
55.2 ± 7.9 0.7630
45 (66.2%) 0.7305
23 (33.8%)
33.75 ± 4.89 0.7256
10 (14.7%) 0.0994
Table 6 Distribution of GERD symptoms in OSA patients in relation to nCPAP therapy.
GERD symptoms in OSA patients (n= 41) Before CPAP therapy After CPAP therapy P-value
GER
Any symptoms (%) 27 (65.85%) 20 (48.78%) 0.1227
Frequent symptoms (%) 11 (26.83%) 7 (17.07%) 0.2921
Nocturnal GER
Any nocturnal symptoms (%) 17 (41.46%) 3 (7.32%) 0.0004
Frequent nocturnal symptoms (%) 9 (21.95%) 1 (2.44%) 0.0077
GERD scores (Mean ± SD) 9.3 ± 2.1 1.8 ± 0.2 <0.0001
Frequency of obstructive sleep apnea 801The above ﬁnding is in concordance with our result. The cur-
rent study showed statistically signiﬁcant increase in percent-
age of OSA in NERD patients than that in ERD ones and
high overall percentage of OSA in GERD patients (Table 2).
Also, in our study, when a comparison was done between
NERD group and ERD one, there was a statistically highly
signiﬁcant increase in AHI (event/hour) and arousal index
(event/hour) in NERD group than that in ERD one. Total
sleep time (min) and Epworth sleepiness scale score showed a
statistically signiﬁcant increase in NERD group than ERD
one. But there were statistically non-signiﬁcant differences
between both groups as regards sleep efﬁciency index (%),
minimum SpO2(%) and SpO2 (%) (Table 5). Several studies
observed that OSA was more common in GERD patients than
in general population and a recent one reported that the fre-
quency of OSA was higher over 10% in GERD patients com-
pared with general population [28] and our result (30.15%) is
in agreement with this ﬁnding. Also Guda et al. [18] found that
AHI was signiﬁcantly higher in group with reﬂux symptoms in
their study, suggesting that the apneic events are more in
patients with reﬂux symptoms than those without reﬂux symp-
toms but the prevalence of sleep apnea was the same in both
groups. These data suggest that reﬂux is not the only mecha-
nism of sleep apnea ‘‘which would increase the prevalence of
apnea in subjects with reﬂux”. Patients with high number of
apneic events may have a higher predisposition to reﬂux due
to the presence of high negative intrathoracic pressure gener-
ated during recovery from an apneic episode. ‘‘In addition,
people with nighttime reﬂux have a higher prevalence of symp-
toms in the oral cavity and airways (oropharyngeal, laryngeal
and pulmonary manifestations)” [29]. Our result is in disagree-
ment with that of Yang et al. [8] who found that GER events
did not cause apnea, arousals, or awakening. The fact that sub-
jective sleep measures of patients showed improvement with
proton pump inhibitors (PPI) with no improvement of objec-
tive parameters suggests that these drugs affect sleep by mech-
anism other than antisecretory one. When GER occurs with
awakening or arousal episode, the sleep onset and/or returning
to sleep may be delayed. Also Ing et al. [3] found weak relation
between OSA and GER as in their study population, only
53.4% of GER events occurred with apneas or hypopneas
and 46.8% of all apneas occurred with GER. So a direct rela-
tion between OSA and GER cannot be present. You et al. [7]
observed high risk for OSA was more in patients with NERD
than in those with ERD and control and our result is in agree-
ment with this ﬁnding. You et al. [7] suggested that NERD
patients may show extraesophageal symptoms. ‘‘Most studies
have shown that NERD patients have other digestive symp-
toms, such as functional dyspepsia and irritable bowelsyndrome, as well as non-digestive symptoms, such as chest
pain, urinary symptoms, mood disorder and sleep dysfunction
with a higher frequency than that observed in ERD patients”
[30]. In agreement with our result, Maher and Darwish, [31]
observed that NERD Egyptian patients had pulmonary man-
ifestations more than ERD patients in their study. ‘‘The patho-
physiological mechanisms proposed to link GERD and OSA
are not mutually exclusive, and it seems possible that the
two conditions may in fact interact, creating a kind of self-
perpetuating positive feedback loop” [32]. During the apnea
period in OSA patients, transdiaphragmatic pressure changes
signiﬁcantly and makes easy migration of the gastric content
toward the esophagus. On the other hand, an irreversible
destruction of the phrenoesophageal ligament occurred due
to repetition of this pressure changes causing lower esophageal
sphincter (LES) insufﬁciency which is a cause of GERD devel-
opment. The large and repeated changes of the pressure gradi-
ent also, presumably, play a role in maintaining the duration
of the reﬂuxate clearance [33]. In the lying position, there is
high pressure gradient, which may cause a migrant reﬂux up
to the pharyngeal region, is easy to occur and cause microaspi-
ration triggering asthmatic or coughing attacks and upper air-
way edema and narrowing. Several forms of sleep-disordered
breathing, such as OSA or snoring could occur due to
increased narrowing of pharyngeal region. In support of this
concept, it is found that during REM sleep, apnea/hypopnea
numbers increased in children with nGER when compared to
children without nGER. During sleep, the muscle control of
the respiratory drive is depressed, so a muscle tone relaxation
in the pharyngeal region is present. Many mechanisms have
been suggested to increase GER in OSA patients including;
low negative intrathoracic pressures, arousals, movements,
low esophageal sphincter tone, and an elevation in the pressure
gradient from the stomach to the lower esophagus [34]. Heine-
mann et al. [35] ‘‘found that 68–76% of patients with OSA had
signiﬁcant GERD. Conversely, nocturnal acid regurgitation,
repetitive microaspiration of gastric acid and vagal reﬂex
may induce OSA in GERD patients”. Sleep itself causes prox-
imal migration of gastric acid and aspiration into the tracheal-
bronchial tree. So many patients with GERD suffer from noc-
turnal reﬂux symptoms [32]. Inﬂammation and edema of upper
airway can result from proximal movement of reﬂuxed gastric
and microaspiration of acid during sleep. This affection of
upper airway, as well as bronchoconstriction predispose to
OSA. The reﬂuxed gastric acid in the distal esophagus in
GERD also stimulates a vagal reﬂex that can cause bron-
chospasm [36]. There are many possible reasons for subjects
with OSA to be prone to nocturnal GER. Firstly, the increase
in negative intrathoracic pressures during upper airway
802 A. Shaker, M. Magdyobstructions may cause breach of the lower esophageal sphinc-
ter, the primary protection against reﬂux. Secondly, these
obstructive events are stopped by disruption of sleep which
caused increased awareness of events and their frequency
because nGER events usually occur in short arousals or awak-
ening from sleep [37]. There is information that, in patients
with GERD, treatment with a PPI or CPAP therapy decreases
OSA severity and also nGERD [17]. Following CPAP therapy,
there were decreases in the number of GER episodes and this
points to the presence of physical factors in a causal associa-
tion between apnea and reﬂux [38]. A second possible pathway
of the hypothesis of apnea-reﬂux association includes chemical
factors and the reﬂuxate matter (acidic, alkaline and neutral
contents as well as gas) as possible stimulants of apnea. ‘‘Acid-
iﬁcation of the proximal or distal esophagus as the mechanism
of OSA has been suggested in both children and adults” [39].
Laryngeal or pharyngeal neuromuscular activity can be chan-
ged because of GER and this may be due to the direct toxic
effect of acid or because of neural reﬂex activity and this
may be considered as a third potential pathway [40]. Prolonged
exposure to acid may impair swallowing reﬂexes in OSA
patients. Local edema of the respiratory tract and increased
secretion of the respiratory mucus may occur due to long expo-
sure of the respiratory tract to stomach contents and acid, and
also may cause lymphoid tissue enlargement [41]. The damage
of subglottic mucosa and vocal folds may occur as a result of
exposure to pepsin from the stomach [42]. In the current study,
after one week of nCPAP therapy, there was a statistically
highly signiﬁcant decrease in percentage of OSA patients (41)
who had any nGER symptoms or frequent nGER. And also,
a statistically highly signiﬁcant decrease in GERD score in
OSA patients after nCPAP therapy was found, but there was
a statistically non-signiﬁcant decrease in percentage of any
GER symptoms and frequent GER symptoms after nCPAP
therapy in those patients. CPAP therapy decreases the preva-
lence of GER, but the mechanism is debated. CPAP can pre-
vent airway obstruction and decrease inspiratory effort, so it
can increase the intrathoracic pressure. Also, CPAP causes
transmission of positive pressure to the intrathoracic airways.
The risk of GER should be decreased after increasing the
intraesophageal pressure in OSA patients with no importance
of reﬂux mechanism involved. Other involved mechanism that
decrease GER after CPAP therapy in OSA patients is an ele-
vation of LES pressure by either reﬂex mechanisms or by
direct mechanical compression of mid-esophagus [43]. Alterna-
tively, the decrease in reﬂux episodes may be related to the
decrease in arousal and movement frequency in OSA patients.
When, a follow-up study was done on patients with both OSA
and GERD using overnight CPAP therapy, both sleep frag-
mentation events, distal esophageal acid exposure time and
reﬂux episode duration were decreased signiﬁcantly [8]. In con-
cordance with our result, Kerr et al. [44] found a signiﬁcant
decrease in arousal and awakening, and also there was a
marked decrease in GER frequency and duration after CPAP
therapy. Further, CPAP therapy also, caused increase the
intraesophageal and LES pressures signiﬁcantly and decrease
GER inpatients who did not have OSA. So, the reduction of
esophageal acid exposure in patients with OSA who used
CPAP is a result of decreasing and weakening the physiologic
changes during sleep events and increasing esophageal pres-
sures [8]. Also, Diaz et al. [45] ‘‘reported that the successful treat-
ment of 5 patients with OSA complaining of severe refractoryreﬂux esophagitis with the use of CPAP”. The reﬂux parame-
ters including; the 24-hour acid contact time (ACT), the mean
reﬂux duration and the mean length of the longest reﬂux event
improved after CPAP therapy. Shepherd et al. [23] reported
that nGER symptoms improved sufﬁciently after 1–6 months
of CPAP therapy. ‘‘Indeed, there was a striking decrease in
the prevalence of nGER in OSA patients after treatment with
CPAP, to levels similar to or lower than that observed in the
low risk group in the general population”.
Conclusions
(1) A high risk for OSA development is more frequent in
GERD patients especially NERD ones and who experi-
ence nighttime symptoms.
(2) There is a mutual relationship between OSA and GERD
reinforcing each other.
(3) CPAP therapy has a good role in the treatment of both
OSA and GERD symptoms.
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